A9-3408

· Alpha-9 Oncology USA Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A9-3408, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma [Phase 1]

See pricing